|Institutional Source||Beutler Lab|
|Gene Name||potassium inwardly-rectifying channel, subfamily J, member 2|
|Synonyms||IRK1, Kcnf1, Kir2.1|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R4605 (G1)|
|Chromosomal Location||111066164-111076821 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||G to A at 111072850 bp|
|Amino Acid Change||Cysteine to Tyrosine at position 356 (C356Y)|
|Ref Sequence||ENSEMBL: ENSMUSP00000037192 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000042970]|
|Predicted Effect||probably damaging
AA Change: C356Y
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: C356Y
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for a targeted null mutation die within 8-12 hours after birth, displaying cyanosis and respiratory distress, as well as complete cleft of the secondary palate, and loss of K+-mediated vasodilatation in cerebral arteries. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Kcnj2||
(F):5'- TGTCATACTGGAAGGCATGGTG -3'
(R):5'- ATATCTCCGATTCTCGCCTTAAGG -3'
(F):5'- CATGGTGGAGGCGACTG -3'
(R):5'- CTCTAGAGGTACGCTTGCCTG -3'